We are now in open enrollment on the government (39 states) or state health insurance exchanges (11 states and the District of Columbia)—so this is the time of year when consumers can buy health insurance coverage under the Affordable Care Act.
In most states, the enrollment season lasts six weeks—half as long as it used to—and many people are wondering whether the ACA is still viable. Hasn’t the Trump administration taken steps to make it easier for healthy individuals to opt out of ACA and buy cheaper coverage that lacks certain popular consumer protections? Doesn’t the economics of covering pre-existing conditions require that all insurance buyers participate in the overall pool of insurance premiums?
There is no question that the alternative, cheaper policies endanger pre-existing coverage in the long term, and many insurance carriers are publicly rethinking their rate policies. But the Affordable Care Act has been surprisingly resilient so far, with 11.8 million Americans signed up for coverage. Insurance companies, for the first time, have reinforced their commitment to the existing system by dropping their rates by an average of 1.5%—though there is wide variation among states. Residents of Tennessee will see a 26% overall decline in the benchmark silver plans, while Pennsylvania residents will experience a 16% decrease. In North Dakota, rates will rise an average of 21%.
In 15 states, insurance companies are returning or entering for the first time, and the total number of providers is up to 155, from 132 last year. That means consumers will have more options. Established insurers like Anthem, and startups like Oscar and Bright are providing coverage because, thanks to a big increase in premiums last year and the possibility that Congress will stall a full ACA repeal going forward, they believe they can scratch out a profit.
Taking the time to navigate the different options can save some consumers thousands of dollars. For instance, many companies are offsetting their rising costs by offering high-deductible, low-premium plans along with health savings accounts (HSAs). An HSA contribution is triple-tax-advantaged: it is deductible when you make the contribution, the money grows tax-deferred, and if you take the money out to pay for medical costs, it comes out tax-free. Any money not used in a calendar year is rolled to the next.
At the other end of the spectrum, people who have developed a chronic condition, or who are older, might fare better with a low-deductible plan. They pay a higher premium each month, but the lower deductible will reduce the amount they will have to pay out-of-pocket for medical procedures. If you buy insurance through an employer, the low-deductible policy can be combined with a flexible spending account, or FSA, where a policyholder contributes pre-tax dollars to pay qualified medical expenses during the year. Any FSA money left over will be forfeited.
There are a lot of issues to consider, which means it might be better to hire an expert than to try to navigate your options on your own. But you have to beware where you get your advice. The Trump administration cut the funding for the ACA’s “navigator” program from $37 million to $10 million. Basically that means there will be fewer sources of impartial advice. Administration officials, instead, are pushing consumers toward sites operated by insurers and for-profit (and sales- oriented) web brokers, who may not provide all the options available to consumers. Getting advice from an “advisor” with a sales agenda is no wiser in the health markets than it is in the investment world.
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial’s solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.